期刊文献+

呼吸机相关肺炎病原菌分布及耐药性分析 被引量:33

Distribution and Drug-resistance of Pathogens in Patients with Ventilator-associated Pneumonia
下载PDF
导出
摘要 目的 研究呼吸机相关肺炎 (VAP)病原菌来源、分布特点及医院内产超广谱 β 内酰胺酶 (ESBLs)细菌的流行特征。方法 对机械通气患者下呼吸道分泌物进行细菌定量培养及抗菌药物敏感性测定 ;对产ESBLs细菌进行检测及质粒酶切图谱分析。结果 VAP病原菌以G-杆菌为主 ,检出产ESBLs细菌 9株 ,均不同程度表现为多重耐药 ;其中 5株来源于RICU产ESBLs肺炎克雷伯菌 ,经质粒酶切图谱分析证实为同一克隆起源。结论 VAP主要是由G-杆菌引起 ,耐药率普遍较高 。 OBJECTIVE To investigate the prevalence and the changes in drug resistance of pathogens in patients with ventilator associated pneumonia (VAP). METHODS The secretion of lower respiratory tract of patients received mechanical ventilation or tracheostomy for more than 48 hours was cultured with a quantitative method and their antibiotic susceptibility was detected with disk diffusion method. At the same time, plasmid mediated extended spectrum β lactamases (ESBLs) were measured by E test, and the epidemiology of ESBLs pathogens was investigated using plasmid restriction endonuclease fingerprinting. RESULTS The main pathogens in VAP were Gram negative bacilli(GNB). Nine of 36 GNB produced ESBLs, and exhibited a multidrug resistance.Plasmid restriction endonuclease analysis proved that plasmid fingerprintings of five Klebsiella pneumoniae strains producing ESBLS from RICU were the same type. CONCLUSIONS GNB are still the most important pathogens in VAP and have resistant to antibiotics. The transferable plasmids play a major role in the spread of the drug resistant bacteria.
出处 《中华医院感染学杂志》 CAS CSCD 2004年第6期693-696,共4页 Chinese Journal of Nosocomiology
关键词 VAP 病原菌 ESBLS 耐药质粒特征 VAP Pathogen ESBLs Drug resistant plasmid profile
  • 相关文献

参考文献5

  • 1Crouch BS,Wunderink RG, Jones CB, et al. Ventilator-associated pneumonia due to Pseudonomas aeruginosa[J]. Chest, 1996, 109(4): 1019-1029.
  • 2Slutsky AS, Treamblay LN. Multiple system organ failure: is mechanical ventilator a contributing factor[J]. Am Rev Respir Dis, 1998, 157: 1721-1728.
  • 3Gunseren F, Mamikoglu L, Ozturk S, et al. A surveillance study of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey[J]. J Antimicrob Chemother, 1999, 43(3): 373-381.
  • 4Quinn JP. Clinical significance of extended-spectrum beta-lactamase[J]. Eur J Clin Microbiol Infect Dis, 1994, Suppl 1: 39-42.
  • 5Pena C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamases in the intensive care unit[J]. J Hosp Infect, 1997, 35: 9.

同被引文献207

引证文献33

二级引证文献330

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部